Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-540-9 | CAS number: 62-54-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
Acute oral toxicity: Key study: The oral LD50 in female rats was 2700 mg/kg bw (test method according to OECD 401).
Acute inhalation toxicity: Key study: The (4h) LC50 in male/female rats was greater than 5.6 mg/L air (test method equivalent to OECD 403).
Acute dermal toxicity: Key study: Read-across from experimental data on the analogue Fumaric Acid. The LD 50 for Calcium Acetate is calculated to be greater than 27247.2 mg/kg bw.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- 1969
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: A scientifically defensible approach was used to conduct the study performed similar to OECD 423 guideline.
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Deviations:
- yes
- Remarks:
- (The pre-specified fixed doses were not use. The test substance was administrated to non-fasted animals)
- Principles of method if other than guideline:
- The doses are arranged in a logarithmic series differing by a factor of two instead of using the pre-specified doses of 5, 50, 300 or 2000 mg/kg bw, as is indicated in the guideline 423.
- GLP compliance:
- no
- Test type:
- fixed dose procedure
- Limit test:
- no
- Species:
- rat
- Strain:
- Wistar
- Sex:
- not specified
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Doses:
- The dosages are arranged in a logarithmic series differing by a factor of two.
- No. of animals per sex per dose:
- Five animals per dose.
- Control animals:
- not specified
- Sex:
- not specified
- Dose descriptor:
- LD50
- Effect level:
- 4 280 mg/kg bw
- Based on:
- test mat.
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The LD50 estimated was 4.28 g/Kg bw of calcium acetate monohydrate.
- Executive summary:
The Acute Oral Toxicity test of calcium acetate monohydrate was performed in Carworth-Wistar male rats.
The dosages are arranged in a logarithmic series differing by a factor of two.
The single oral dose toxicity was estimated by the gastric intubation of a 0.100 g/ml water solution test substance to groups of five non-fasted rats.
The LD50 estimated was 4.28 g/Kg bw of calcium acetate monohydrate
Reference
The single oral LD50 for rats is 4.28 g/Kg bw.
Endpoint conclusion
- Dose descriptor:
- LD50
- Value:
- 2 700 mg/kg bw
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From 1982-01-26 to 1982-02-09.
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Test was realized using a method equivalent to OECD 403 guideline.
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- Deviations:
- no
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Chbb Thom (from THOMAE GmbH) Biberach/Riss
- Age at study initiation: 8 weeks
- Weight at study initiation: males: 228+/-9g and females. 195+/-20g.
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22+/-2ºC
- Humidity (%): 55+/-5%
- Photoperiod (hrs dark / hrs light):12h/12h - Route of administration:
- inhalation: aerosol
- Type of inhalation exposure:
- nose/head only
- Vehicle:
- air
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: Vibratomat - (BASF) generating air -dust mixture.
- Exposure chamber volume: 55L
- Source and rate of air: flow rates were set: 1500 L/h air through the injector and 1500 L/ h induced air as dilution air.
- Method of conditioning air: was established that the substance-air mixture in the breathing zone the animals are not diluted by laboratory air
- System of generating particulates/aerosols: to generate a dust aerosol of the test substance a dust generator ( Vibratomat)was used, which sent the dust to the inhalation device.
- Method of particle size determination: The experimental group sample was collected earlier than 30 minutes after the test, for particle size analysis. Effective cutoff aerodynamic diameter 50% was determinated.
- Temperature, humidity, pressure in air chamber: controlled
TEST ATMOSPHERE
- Brief description of analytical method used: the dust concentration was calculated from the difference between filters.
- Samples taken from breathing zone: yes - Analytical verification of test atmosphere concentrations:
- yes
- Duration of exposure:
- 4 h
- Concentrations:
- 5.6 mg/L
- No. of animals per sex per dose:
- 10
- Control animals:
- yes
- Details on study design:
- - Duration of observation period following administration: 14 days (or other?)
- Frequency of observations and weighing: 7 and 14 days
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs - Sex:
- female
- Dose descriptor:
- LC50
- Effect level:
- > 5.6 mg/L air (analytical)
- Based on:
- test mat.
- 95% CL:
- 0.5
- Exp. duration:
- 4 h
- Remarks on result:
- other: CL values corresponds to SD value.
- Mortality:
- No mortality observed.
- Clinical signs:
- other: No changes observed.
- Body weight:
- female 0 days:195
female 7 days:205
female 14 days:224
male 0 days:228
male 7 days:257
male 14 days:292 - Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- LC50 value for 4 hours exposition at rat (male and female) is higher than 5.6 mg/L. At the dose no mortality was observed as well as any change during the pathology observations realized at the end of the study at 14 days.
- Executive summary:
Calcium acetate LC50value for 4 hours exposition at rat (male and female) is higher than 5.6 mg/L. At the dose no mortality was observed as well as any change during the pathology observations realized at the end of the study at 14 days.The substance is considered as nontoxic.
Reference
Endpoint conclusion
- Dose descriptor:
- LC50
- Value:
- 5 600 mg/m³ air
Acute toxicity: via dermal route
Endpoint conclusion
- Dose descriptor:
- LD50
- Value:
- 27 247.2 mg/kg bw
Additional information
Acute oral toxicity:
Key study:
Experimental results: Test method was according to OECD 401.
The oral LD50 of Calcium acetate was 2700 mg/kw/bw (in female rats was 1943 mg/kg bw, and LD50 for male rats was between 3160 and 4640 mg/kg bw).
Acute inhalation toxicity:
Key study:
Experimental results: Test method was similar to OECD 403.
The LC50 value for 4 hours exposition at rat (male and female) is higher than 5.6 mg/L. At this dose no mortality was observed as well as any change during the pathology observations realized at the end of the study at 14 days.
Acute dermal toxicity:
Key study:
Experimental results from a study similar to OECD 402 guideline on the analogue Fumaric Acid. The LD50 for Fumaric Acid is greater than 20000 mg/kg bw for rabbits.
Based on this experimental result and the molecular weights, the read-across approach is applied and the LD 50 for Calcium Acetate is calculated to be greater than 27247.2 mg/kg bw.
Justification for classification or non-classification
Acute toxicity:
Oral: LC50>2000mg/kg bw: non- classification
Dermal: LC50>2000mg/kg bw: non- classification
Inhalation: LC50>5 mg/L: non-classification
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
